Vistagen Therapeutics (VTGN) Q2 2025 Earnings

17JunConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.51
-0.46
-0.4
-0.35

Details

Expected EPS
-0.496667
Actual EPS
-0.43
Surprise EPS
0.07
Surprise Percent
+13.42%

Description

Vistagen Therapeutics (VTGN) has reported earnings of -0.43 per share for Q2 2025.

0 Comments

Share your thoughts